Page last updated: 2024-11-02

oxybutynin and Heart Disease, Ischemic

oxybutynin has been researched along with Heart Disease, Ischemic in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research Excerpts

ExcerptRelevanceReference
" Pharmacokinetic software 3p97 was applied to calculate pharmacokinetic parameters and the area under the drug concentration-time curve (AUC) in various tissues."1.37Pharmacokinetics of ligustrazine ethosome patch in rats and anti-myocardial ischemia and anti-ischemic reperfusion injury effect. ( He, Z; Liu, H; Liu, J; Liu, X; Zeng, Z; Zhou, W, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, X1
Liu, H1
Zeng, Z1
Zhou, W1
Liu, J1
He, Z1

Other Studies

1 other study available for oxybutynin and Heart Disease, Ischemic

ArticleYear
Pharmacokinetics of ligustrazine ethosome patch in rats and anti-myocardial ischemia and anti-ischemic reperfusion injury effect.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Animals; Area Under Curve; Blood Viscosity; Chi-Square Distribution; Fibrinolytic Agents; Male; Myoc

2011